NANEXA — Nanexa AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Nanexa AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	—	—	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	106	81.2	65.2	10.3	44.6
Net Total Accounts Receivable
Net Total Receivables	2.07	5.47	6.25	6.77	8.88
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	109	89.7	77.3	19.5	53.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.75	15.1	14.3	12.6	9.84
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	165	170	132	91.8	138
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.1	38.8	30.6	18.7	35.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.7	61.1	36.4	20.9	36.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	151	109	95.8	70.9	102
Total Liabilities & Shareholders' Equity	165	170	132	91.8	138
Total Common Shares Outstanding